{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:31:44Z","timestamp":1759228304680},"reference-count":144,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Mol Med"],"DOI":"10.3892\/ijmm.2018.3361","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T11:56:37Z","timestamp":1514980597000},"source":"Crossref","is-referenced-by-count":9,"title":["Genetically\u2011modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)\u2011based targeted therapy (Review)"],"prefix":"10.3892","author":[{"given":"Marina","family":"Devetzi","sequence":"first","affiliation":[{"name":"Biomedical Applications Unit, Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 11635 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Goulielmaki","sequence":"additional","affiliation":[{"name":"Biomedical Applications Unit, Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 11635 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Khoury","sequence":"additional","affiliation":[{"name":"Biomedical Applications Unit, Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 11635 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrios","family":"Spandidos","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Virology, Medical School, University of Crete, 71003 Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Sotiropoulou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Patras, Rion, 26500 Patras, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Christodoulou","sequence":"additional","affiliation":[{"name":"Biomedical Applications Unit, Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 11635 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilis","family":"Zoumpourlis","sequence":"additional","affiliation":[{"name":"Biomedical Applications Unit, Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 11635 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,1,3]]},"reference":[{"key":"key20200713174550_b1-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1254\/jphs.SRJ05001X","article-title":"The kallikrein-kinin system: Current and future pharmacological targets","volume":"99","author":"Moreau","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"key20200713174550_b2-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/1354750X.2013.787544","article-title":"The kinin-kallikrein system: Physiological roles, pathophysiology and its relationship to cancer biomarkers","volume":"18","author":"Kashuba","year":"2013","journal-title":"Biomarkers"},{"key":"key20200713174550_b3-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.npep.2009.12.005","article-title":"Distribution and expression of B2-kinin receptor on human leukocyte subsets in young adults and elderly using flow cytometry","volume":"44","author":"Bourdet","year":"2010","journal-title":"Neuropeptides"},{"key":"key20200713174550_b4-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1515\/BC.2006.085","article-title":"The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction","volume":"387","author":"Chao","year":"2006","journal-title":"Biol Chem"},{"key":"key20200713174550_b5-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.molonc.2007.09.003","article-title":"New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family","volume":"1","author":"Emami","year":"2007","journal-title":"Mol Oncol"},{"key":"key20200713174550_b6-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2174\/187152509789105444","article-title":"Human plasma kallikrein-kinin system: Physiological and biochemical parameters","volume":"7","author":"Bryant","year":"2009","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"key20200713174550_b7-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/apha.12007","article-title":"The kallikrein-kinin system","volume":"206","author":"Hillmeister","year":"2012","journal-title":"Acta Physiol (Oxf)"},{"key":"key20200713174550_b8-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1160\/TH13-03-0258","article-title":"Plasma kallikrein: The bradykinin-producing enzyme","volume":"110","author":"Bj\u00f6rkqvist","year":"2013","journal-title":"Thromb Haemost"},{"key":"key20200713174550_b9-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/nrc1474","article-title":"The emerging roles of human tissue kallikreins in cancer","volume":"4","author":"Borgo\u00f1o","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"key20200713174550_b10-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"32989","DOI":"10.1074\/jbc.R109.027946","article-title":"Functional roles of human kallikrein-related peptidases","volume":"284","author":"Sotiropoulou","year":"2009","journal-title":"J Biol Chem"},{"key":"key20200713174550_b11-ijmm-41-03-1177","first-page":"228","article-title":"Applications of mesenchymal stem cells: An updated review","volume":"31","author":"Lee","year":"2008","journal-title":"Chang Gung Med J"},{"key":"key20200713174550_b12-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"246134","DOI":"10.1155\/2013\/246134","article-title":"Comparative evaluation of human mesenchymal stem cells of fetal (Wharton\u2019s jelly) and adult (adipose tissue) origin during prolonged in vitro expansion: Considerations for cytotherapy","volume":"2013","author":"Christodoulou","year":"2013","journal-title":"Stem Cells Int"},{"key":"key20200713174550_b13-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"e2995","DOI":"10.1002\/jgm.2995","article-title":"Mesenchymal stem cells therapy: A promising cell based therapy for treatment of myocardial infraction","volume":"19","author":"Shafei","year":"2017","journal-title":"J Gene Med"},{"key":"key20200713174550_b14-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"30015","DOI":"10.3390\/ijms161226215","article-title":"Mesenchymal stem cell-mediated effects of tumor support or suppression","volume":"16","author":"Rhee","year":"2015","journal-title":"Int J Mol Sci"},{"key":"key20200713174550_b15-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"key20200713174550_b16-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1161\/01.CIR.0000058702.69484.A0","article-title":"Peripheral blood \u2018endothelial progenitor cells\u2019 are derived from monocyte\/macrophages and secrete angiogenic growth factors","volume":"107","author":"Rehman","year":"2003","journal-title":"Circulation"},{"key":"key20200713174550_b17-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1582-4934.2004.tb00474.x","article-title":"Endothelial progenitor cells: Characterization, pathophysiology, and possible clinical relevance","volume":"8","author":"Hristov","year":"2004","journal-title":"J Cell Mol Med"},{"key":"key20200713174550_b18-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2174\/157016112798829832","article-title":"\u2018Endothelial progenitor cells\u2019 as a therapeutic strategy in cardiovascular disease","volume":"10","author":"Kr\u00e4nkel","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"key20200713174550_b19-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"e73035","DOI":"10.1371\/journal.pone.0073035","article-title":"Kallikrein gene-modified EPCs induce angiogenesis in rats with ischemic hindlimb and correlate with integrin \u03b1v\u03b23 expression","volume":"8","author":"Fu","year":"2013","journal-title":"PLoS One"},{"key":"key20200713174550_b20-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1960804","DOI":"10.1155\/2017\/1960804","article-title":"The use of endothelial progenitor cells for the regeneration of musculoskeletal and neural tissues","volume":"2017","author":"Kamei","year":"2017","journal-title":"Stem Cells Int"},{"key":"key20200713174550_b21-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.kint.2015.11.023","article-title":"Challenges and opportunities for stem cell therapy in patients with chronic kidney disease","volume":"89","author":"Hickson","year":"2016","journal-title":"Kidney Int"},{"key":"key20200713174550_b22-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"2193432","DOI":"10.1155\/2017\/2193432","article-title":"Endothelial progenitor cells for ischemic stroke: Update on basic research and application","volume":"2017","author":"Liao","year":"2017","journal-title":"Stem Cells Int"},{"key":"key20200713174550_b23-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.jcyt.2016.09.003","article-title":"Genetically modified mesenchymal stromal cells in cancer therapy","volume":"18","author":"Sage","year":"2016","journal-title":"Cytotherapy"},{"key":"key20200713174550_b24-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"key20200713174550_b25-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1158\/0008-5472.CAN-08-3562","article-title":"Mesenchymal stem cells: Flip side of the coin","volume":"69","author":"Mishra","year":"2009","journal-title":"Cancer Res"},{"key":"key20200713174550_b26-ijmm-41-03-1177","first-page":"608","article-title":"Immunosuppressive effects of rat mesenchymal stem cells: Involvement of CD4+CD25+ regulatory T cells","volume":"7","author":"Ye","year":"2008","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"key20200713174550_b27-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1038\/leu.2011.167","article-title":"Bone marrow stem cell mobilization in stroke: A \u2018bonehead\u2019 may be good after all!","volume":"25","author":"Borlongan","year":"2011","journal-title":"Leukemia"},{"key":"key20200713174550_b28-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1182\/blood-2004-11-4349","article-title":"Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells","volume":"105","author":"Kortesidis","year":"2005","journal-title":"Blood"},{"key":"key20200713174550_b29-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S1472-6483(10)60539-1","article-title":"Comparative growth behaviour and characterization of stem cells from human Wharton\u2019s jelly","volume":"15","author":"Fong","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"key20200713174550_b30-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12015-010-9166-x","article-title":"Human Wharton\u2019s jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells","volume":"7","author":"Fong","year":"2011","journal-title":"Stem Cell Rev"},{"key":"key20200713174550_b31-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1634\/stemcells.2007-1028","article-title":"Immune properties of human umbilical cord Wharton\u2019s jelly-derived cells","volume":"26","author":"Weiss","year":"2008","journal-title":"Stem Cells"},{"key":"key20200713174550_b32-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2174\/1875043501104010028","article-title":"Wharton\u2019s jelly mesenchymal stem cells as off-the-shelf cellular therapeutics: A closer look into their regenerative and immunomodulatory properties","volume":"4","author":"Prasanna","year":"2011","journal-title":"Open Tissue Eng Regen Med J"},{"key":"key20200713174550_b33-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2143\/AC.60.3.2005005","article-title":"Differentiation, engraftment and functional effects of pre-treated mesenchymal stem cells in a rat myocardial infarct model","volume":"60","author":"Yoon","year":"2005","journal-title":"Acta Cardiol"},{"key":"key20200713174550_b34-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ejcts.2006.02.070","article-title":"Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion","volume":"30","author":"Tang","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"key20200713174550_b35-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.echo.2006.11.008","article-title":"Stem cell therapy improves myocardial perfusion and cardiac synchronicity: New application for echocardiography","volume":"20","author":"Wolf","year":"2007","journal-title":"J Am Soc Echocardiogr"},{"key":"key20200713174550_b36-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000093609","article-title":"Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction","volume":"107","author":"Yang","year":"2007","journal-title":"Cardiology"},{"key":"key20200713174550_b37-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10753-007-9025-3","article-title":"Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction","volume":"30","author":"Guo","year":"2007","journal-title":"Inflammation"},{"key":"key20200713174550_b38-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/00019501-200506000-00006","article-title":"Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats","volume":"16","author":"Xu","year":"2005","journal-title":"Coron Artery Dis"},{"key":"key20200713174550_b39-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1253\/circj.CJ-12-1585","article-title":"Tissue kallikrein-modified mesenchymal stem cells provide enhanced protection against ischemic cardiac injury after myocardial infarction","volume":"77","author":"Gao","year":"2013","journal-title":"Circ J"},{"key":"key20200713174550_b40-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"11474","DOI":"10.1073\/pnas.0504388102","article-title":"Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction","volume":"102","author":"Amado","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713174550_b41-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/jcb.26169","article-title":"Stem cell therapy: A new therapeutic option for cardiovascular diseases","volume":"119","author":"Goradel","year":"2018","journal-title":"J Cell Biochem"},{"key":"key20200713174550_b42-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"H1001","DOI":"10.1152\/ajpheart.00716.2003","article-title":"Superoxide, H2O2, and iron are required for TNF-alpha-induced MCP-1 gene expression in endothelial cells: Role of Rac1 and NADPH oxidase","volume":"286","author":"Chen","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key20200713174550_b43-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jcb.20886","article-title":"Mesenchymal stem cells as trophic mediators","volume":"98","author":"Caplan","year":"2006","journal-title":"J Cell Biochem"},{"key":"key20200713174550_b44-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1253\/circj.CJ-11-1479","article-title":"Perspectives on stem cell therapy for cardiac regeneration. Advances and challenges","volume":"76","author":"Choi","year":"2012","journal-title":"Circ J"},{"key":"key20200713174550_b45-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/MCA.0b013e3283640f00","article-title":"Wharton\u2019s jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarction","volume":"24","author":"Zhang","year":"2013","journal-title":"Coron Artery Dis"},{"key":"key20200713174550_b46-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1634\/stemcells.2005-0370","article-title":"Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation","volume":"24","author":"Deng","year":"2006","journal-title":"Stem Cells"},{"key":"key20200713174550_b47-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1634\/stemcells.2005-0636","article-title":"Functional neuronal differentiation of bone marrow-derived mesenchymal stem cells","volume":"24","author":"Tropel","year":"2006","journal-title":"Stem Cells"},{"key":"key20200713174550_b48-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1292\/jvms.69.95","article-title":"Spontaneous differentiation of adult rat marrow stromal cells in a long-term culture","volume":"69","author":"Tseng","year":"2007","journal-title":"J Vet Med Sci"},{"key":"key20200713174550_b49-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1517\/14712598.5.4.427","article-title":"Treatment of neurodegenerative diseases using adult bone marrow stromal cell-derived neurons","volume":"5","author":"Dezawa","year":"2005","journal-title":"Expert Opin Biol Ther"},{"key":"key20200713174550_b50-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1038\/emm.2013.2","article-title":"The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation","volume":"45","author":"Kim","year":"2013","journal-title":"Exp Mol Med"},{"key":"key20200713174550_b51-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/2001-1326-3-24","article-title":"Stem cell delivery of therapies for brain disorders","volume":"3","author":"Aleynik","year":"2014","journal-title":"Clin Transl Med"},{"key":"key20200713174550_b52-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1089\/scd.2008.0018","article-title":"Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular \u03b2-amyloid deposits in Alzheimer mice","volume":"17","author":"Nikolic","year":"2008","journal-title":"Stem Cells Dev"},{"key":"key20200713174550_b53-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2174\/1574888X09666140923101110","article-title":"Mesenchymal stem cells: Potential in treatment of neurodegenerative diseases","volume":"9","author":"Tanna","year":"2014","journal-title":"Curr Stem Cell Res Ther"},{"key":"key20200713174550_b54-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3389\/fphar.2017.00628","article-title":"Human umbilical cord blood cell transplantation in neuroregenerative strategies","volume":"8","author":"Galieva","year":"2017","journal-title":"Front Pharmacol"},{"key":"key20200713174550_b55-ijmm-41-03-1177","article-title":"Killing two birds with one stone: The multifunctional roles of mesenchymal stem cells in the treatment of neurodegenerative and muscle diseases","author":"Lee","year":"2017","journal-title":"Histol Histopathol"},{"key":"key20200713174550_b56-ijmm-41-03-1177","doi-asserted-by":"crossref","DOI":"10.5772\/53336","article-title":"Mesenchymal stem cells from extra-embryonic tissues for tissue engineering - regeneration of the peripheral nerve","volume-title":"Advances in Biomaterials Science and Biomedical Applications","author":"G\u00e4rtner","year":"2013"},{"key":"key20200713174550_b57-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/B978-0-12-410499-0.00004-6","article-title":"Perspectives of employing mesenchymal stem cells from the Wharton\u2019s jelly of the umbilical cord for peripheral nerve repair","volume":"108","author":"Ribeiro","year":"2013","journal-title":"Int Rev Neurobiol"},{"key":"key20200713174550_b58-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"367","DOI":"10.4252\/wjsc.v8.i11.367","article-title":"Renal progenitors: Roles in kidney disease and regeneration","volume":"8","author":"Chambers","year":"2016","journal-title":"World J Stem Cells"},{"key":"key20200713174550_b59-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"4798639","DOI":"10.1155\/2016\/4798639","article-title":"Mesenchymal stem cell-based therapy for kidney disease: A review of clinical evidence","volume":"2016","author":"Peired","year":"2016","journal-title":"Stem Cells Int"},{"key":"key20200713174550_b60-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s13287-017-0727-7","article-title":"Mesenchymal stem cell-derived extracellular vesicles for kidney repair: Current status and looming challenges","volume":"8","author":"Aghajani Nargesi","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"key20200713174550_b61-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"F31","DOI":"10.1152\/ajprenal.00007.2005","article-title":"Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms","volume":"289","author":"T\u00f6gel","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"key20200713174550_b62-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1111\/j.1523-1755.2005.00573.x","article-title":"Administered mesenchymal stem cells enhance recovery from ischemia\/reperfusion-induced acute renal failure in rats","volume":"68","author":"Lange","year":"2005","journal-title":"Kidney Int"},{"key":"key20200713174550_b63-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"448","DOI":"10.4252\/wjsc.v6.i4.448","article-title":"Kallikrein-kinin in stem cell therapy","volume":"6","author":"Chao","year":"2014","journal-title":"World J Stem Cells"},{"key":"key20200713174550_b64-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.bbmt.2009.07.022","article-title":"Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice","volume":"15","author":"Ezquer","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"key20200713174550_b65-ijmm-41-03-1177","first-page":"85","article-title":"Autologous transplantation of adipose-derived mesenchymal stem cells ameliorates streptozotocin-induced diabetic nephropathy in rats by inhibiting oxidative stress, pro-inflammatory cytokines and the p38 MAPK signaling pathway","volume":"30","author":"Fang","year":"2012","journal-title":"Int J Mol Med"},{"key":"key20200713174550_b66-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1159\/000354473","article-title":"Bone marrow-derived mononuclear cells promote improvement in glomerular function in rats with early diabetic nephropathy","volume":"32","author":"Castiglione","year":"2013","journal-title":"Cell Physiol Biochem"},{"key":"key20200713174550_b67-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/stem.1263","article-title":"Mesenchymal stem cells and endothelial progenitor cells decrease renal injury in experimental swine renal artery stenosis through different mechanisms","volume":"31","author":"Zhu","year":"2013","journal-title":"Stem Cells"},{"key":"key20200713174550_b68-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/stem.1047","article-title":"Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis","volume":"30","author":"Eirin","year":"2012","journal-title":"Stem Cells"},{"key":"key20200713174550_b69-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0002-9440(10)62276-6","article-title":"Isolation of renal progenitor cells from adult human kidney","volume":"166","author":"Bussolati","year":"2005","journal-title":"Am J Pathol"},{"key":"key20200713174550_b70-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1002\/stem.1130","article-title":"Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury","volume":"30","author":"Angelotti","year":"2012","journal-title":"Stem Cells"},{"key":"key20200713174550_b71-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1242\/dmm.017699","article-title":"Cell-based therapies for experimental chronic kidney disease: A systematic review and meta-analysis","volume":"8","author":"Papazova","year":"2015","journal-title":"Dis Model Mech"},{"key":"key20200713174550_b72-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/MAJ.0b013e3182831777","article-title":"Human umbilical mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis","volume":"346","author":"Ma","year":"2013","journal-title":"Am J Med Sci"},{"key":"key20200713174550_b73-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.biologicals.2013.09.004","article-title":"Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis","volume":"41","author":"Belingheri","year":"2013","journal-title":"Biologicals"},{"key":"key20200713174550_b74-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/stem.68","article-title":"Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans","volume":"27","author":"Sun","year":"2009","journal-title":"Stem Cells"},{"key":"key20200713174550_b75-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/art.27548","article-title":"Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus","volume":"62","author":"Sun","year":"2010","journal-title":"Arthritis Rheum"},{"key":"key20200713174550_b76-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1089\/scd.2015.0008","article-title":"Mesenchymal stem cell therapy for autoimmune disease: Risks and rewards","volume":"24","author":"Munir","year":"2015","journal-title":"Stem Cells Dev"},{"key":"key20200713174550_b77-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4252\/wjsc.v7.i2.343","article-title":"Stem cell therapy in inflammatory bowel disease: A promising therapeutic strategy?","volume":"7","author":"Flores","year":"2015","journal-title":"World J Stem Cells"},{"key":"key20200713174550_b78-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"e46504","DOI":"10.1371\/journal.pone.0046504","article-title":"Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury","volume":"7","author":"Fang","year":"2012","journal-title":"PLoS One"},{"key":"key20200713174550_b79-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/07853890601073429","article-title":"Endothelial progenitor cells in health and atherosclerotic disease","volume":"39","author":"Werner","year":"2007","journal-title":"Ann Med"},{"key":"key20200713174550_b80-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.yjmcc.2008.08.003","article-title":"Endothelial progenitor cells in neovascularization of infarcted myocardium","volume":"45","author":"Jujo","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"key20200713174550_b81-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1161\/01.ATV.0000133488.56221.4a","article-title":"Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure","volume":"24","author":"Choi","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20200713174550_b82-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/hh1301.093953","article-title":"Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease","volume":"89","author":"Vasa","year":"2001","journal-title":"Circ Res"},{"key":"key20200713174550_b83-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00395-007-0685-9","article-title":"Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model","volume":"103","author":"Schuh","year":"2008","journal-title":"Basic Res Cardiol"},{"key":"key20200713174550_b84-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1254\/jphs.08R01CP","article-title":"Endothelial progenitor cells: Therapeutic target for cardiovascular diseases","volume":"108","author":"Umemura","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"key20200713174550_b85-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1089\/hum.2011.123","article-title":"Tissue kallikrein promotes cardiac neovascularization by enhancing endothelial progenitor cell functional capacity","volume":"23","author":"Yao","year":"2012","journal-title":"Hum Gene Ther"},{"key":"key20200713174550_b86-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"8270498","DOI":"10.1155\/2017\/8270498","article-title":"Progenitor cells for arterial repair: Incremental advancements towards therapeutic reality","volume":"2017","author":"Simard","year":"2017","journal-title":"Stem Cells Int"},{"key":"key20200713174550_b87-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1369\/jhc.2010.956011","article-title":"Bone marrow-derived endothelial progenitor cells and endothelial cells may contribute to endothelial repair in the kidney immediately after ischemia-reperfusion","volume":"58","author":"Kwon","year":"2010","journal-title":"J Histochem Cytochem"},{"key":"key20200713174550_b88-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"F176","DOI":"10.1152\/ajprenal.00454.2005","article-title":"Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: Modulation by ischemic preconditioning","volume":"291","author":"Patschan","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"key20200713174550_b89-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"e73244","DOI":"10.1371\/journal.pone.0073244","article-title":"Factors secreted by endothelial progenitor cells enhance neurorepair responses after cerebral ischemia in mice","volume":"8","author":"Rosell","year":"2013","journal-title":"PLoS One"},{"key":"key20200713174550_b90-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13045-015-0130-8","article-title":"Endothelial progenitor cells in ischemic stroke: An exploration from hypothesis to therapy","volume":"8","author":"Li","year":"2015","journal-title":"J Hematol Oncol"},{"key":"key20200713174550_b91-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/nm912","article-title":"Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts","volume":"9","author":"Mangi","year":"2003","journal-title":"Nat Med"},{"key":"key20200713174550_b92-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.jacc.2005.07.023","article-title":"Enhancing stem cell therapy through genetic modification","volume":"46","author":"Dzau","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key20200713174550_b93-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4252\/wjsc.v6.i2.82","article-title":"Enhancing the efficacy of mesenchymal stem cell therapy","volume":"6","author":"Mastri","year":"2014","journal-title":"World J Stem Cells"},{"key":"key20200713174550_b94-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ymeth.2015.03.002","article-title":"Engineering mesenchymal stem cells for regenerative medicine and drug delivery","volume":"84","author":"Park","year":"2015","journal-title":"Methods"},{"key":"key20200713174550_b95-ijmm-41-03-1177","article-title":"Mesenchymal stem cells: A new platform for targeting suicide genes in cancer","author":"Moradian Tehrani","year":"2017","journal-title":"J Cell Physiol"},{"key":"key20200713174550_b96-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.jacc.2005.05.079","article-title":"Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector","volume":"46","author":"Tang","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key20200713174550_b97-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1161\/01.ATV.0000165696.25680.ce","article-title":"Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction","volume":"25","author":"Matsumoto","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20200713174550_b98-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/stem.12","article-title":"Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction","volume":"27","author":"Gnecchi","year":"2009","journal-title":"Stem Cells"},{"key":"key20200713174550_b99-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1089\/scd.2009.0495","article-title":"Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury","volume":"20","author":"Chen","year":"2011","journal-title":"Stem Cells Dev"},{"key":"key20200713174550_b100-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"F207","DOI":"10.1152\/ajprenal.00073.2010","article-title":"VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury","volume":"300","author":"Yuan","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"key20200713174550_b101-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pharmthera.2012.04.002","article-title":"Impact of kinins in the treatment of cardiovascular diseases","volume":"135","author":"Regoli","year":"2012","journal-title":"Pharmacol Ther"},{"key":"key20200713174550_b102-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1042\/bj2670639","article-title":"Identification, purification, and localization of tissue kallikrein in rat heart","volume":"267","author":"Xiong","year":"1990","journal-title":"Biochem J"},{"key":"key20200713174550_b103-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1161\/01.HYP.23.6.919","article-title":"A local kallikrein-kinin system is present in rat hearts","volume":"23","author":"Nolly","year":"1994","journal-title":"Hypertension"},{"key":"key20200713174550_b104-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/002215549904700210","article-title":"Localization and expression of tissue kallikrein and kallistatin in human blood vessels","volume":"47","author":"Wolf","year":"1999","journal-title":"J Histochem Cytochem"},{"key":"key20200713174550_b105-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/01.HYP.0000036035.41122.99","article-title":"Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction","volume":"40","author":"Agata","year":"2002","journal-title":"Hypertension"},{"key":"key20200713174550_b106-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.regpep.2006.11.020","article-title":"Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction","volume":"140","author":"Yao","year":"2007","journal-title":"Regul Pept"},{"key":"key20200713174550_b107-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/cvr\/cvn223","article-title":"Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway","volume":"80","author":"Yao","year":"2008","journal-title":"Cardiovasc Res"},{"key":"key20200713174550_b108-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"8022","DOI":"10.1074\/jbc.M407179200","article-title":"Kallikrein\/kinin protects against myocardial apoptosis after ischemia\/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways","volume":"280","author":"Yin","year":"2005","journal-title":"J Biol Chem"},{"key":"key20200713174550_b109-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.intimp.2007.07.022","article-title":"New perspective on the tissue kallikrein-kinin system in myocardial infarction: Role of angiogenesis and cardiac regeneration","volume":"8","author":"Westermann","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"key20200713174550_b110-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.lfs.2007.10.021","article-title":"Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia\/reperfusion","volume":"82","author":"Yin","year":"2008","journal-title":"Life Sci"},{"key":"key20200713174550_b111-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/01.HYP.31.5.1104","article-title":"Kallikrein gene delivery attenuates hypertension and cardiac hypertrophy and enhances renal function in Goldblatt hypertensive rats","volume":"31","author":"Yayama","year":"1998","journal-title":"Hypertension"},{"key":"key20200713174550_b112-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1046\/j.1523-1755.2000.00219.x","article-title":"Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure","volume":"58","author":"Wolf","year":"2000","journal-title":"Kidney Int"},{"key":"key20200713174550_b113-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"H1479","DOI":"10.1152\/ajpheart.01129.2002","article-title":"Kallikrein gene delivery attenuates cardiac remodeling and promotes neovascularization in spontaneously hypertensive rats","volume":"285","author":"Bledsoe","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key20200713174550_b114-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1515\/bc.2010.042","article-title":"Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing","volume":"391","author":"Chao","year":"2010","journal-title":"Biol Chem"},{"key":"key20200713174550_b115-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2217\/17460751.1.2.235","article-title":"Regional and global protective effects of tissue kallikrein gene delivery to the peri-infarct myocardium","volume":"1","author":"Spillmann","year":"2006","journal-title":"Regen Med"},{"key":"key20200713174550_b116-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1161\/01.CIR.103.1.125","article-title":"Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia","volume":"103","author":"Emanueli","year":"2001","journal-title":"Circulation"},{"key":"key20200713174550_b117-ijmm-41-03-1177","first-page":"679","article-title":"Angiogenesis therapy with human tissue kallikrein for the treatment of ischemic diseases","volume":"97","author":"Emanueli","year":"2004","journal-title":"Arch Mal Coeur Vaiss"},{"key":"key20200713174550_b118-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0162-3109(99)00120-4","article-title":"Adenovirus-mediated kallikrein gene transfer inhibits neointima formation via increased production of nitric oxide in rat artery","volume":"44","author":"Murakami","year":"1999","journal-title":"Immunopharmacology"},{"key":"key20200713174550_b119-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1161\/01.HYP.34.2.164","article-title":"Kallikrein gene delivery inhibits vascular smooth muscle cell growth and neointima formation in the rat artery after balloon angioplasty","volume":"34","author":"Murakami","year":"1999","journal-title":"Hypertension"},{"key":"key20200713174550_b120-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1089\/hum.2008.016","article-title":"Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation","volume":"19","author":"Hagiwara","year":"2008","journal-title":"Hum Gene Ther"},{"key":"key20200713174550_b121-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.jacc.2011.06.058","article-title":"New targets to treat the structural remodeling of the myocardium","volume":"58","author":"Gonz\u00e1lez","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key20200713174550_b122-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1096\/fj.03-0736com","article-title":"Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene","volume":"18","author":"Tsch\u00f6pe","year":"2004","journal-title":"FASEB J"},{"key":"key20200713174550_b123-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/labinvest.2013.48","article-title":"Tissue kallikrein-modified human endothelial progenitor cell implantation improves cardiac function via enhanced activation of akt and increased angiogenesis","volume":"93","author":"Yao","year":"2013","journal-title":"Lab Invest"},{"key":"key20200713174550_b124-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0162-3109(99)00089-2","article-title":"Tissue kallikrein and kinins in renal disease","volume":"44","author":"Naicker","year":"1999","journal-title":"Immunopharmacology"},{"key":"key20200713174550_b125-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1254\/jphs.CRJ06003X","article-title":"A missing link between a high salt intake and blood pressure increase","volume":"100","author":"Katori","year":"2006","journal-title":"J Pharmacol Sci"},{"key":"key20200713174550_b126-ijmm-41-03-1177","first-page":"15","article-title":"The kallikrein-kinin pathways in hypertension and diabetes","volume":"69","author":"Sharma","year":"2014","journal-title":"Prog Drug Res"},{"key":"key20200713174550_b127-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1161\/01.HYP.24.6.770","article-title":"Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats","volume":"24","author":"Uehara","year":"1994","journal-title":"Hypertension"},{"key":"key20200713174550_b128-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1046\/j.1523-1755.1998.00104.x","article-title":"Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats","volume":"54","author":"Chao","year":"1998","journal-title":"Kidney Int"},{"key":"key20200713174550_b129-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000045275","article-title":"Regression of glomerular injury by kallikrein infusion in Dahl salt-sensitive rats is a bradykinin B2-receptor-mediated event","volume":"81","author":"Hirawa","year":"1999","journal-title":"Nephron"},{"key":"key20200713174550_b130-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1089\/hum.2006.17.545","article-title":"Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery","volume":"17","author":"Bledsoe","year":"2006","journal-title":"Hum Gene Ther"},{"key":"key20200713174550_b131-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1523-1755.2004.00794.x","article-title":"Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress","volume":"66","author":"Zhang","year":"2004","journal-title":"Kidney Int"},{"key":"key20200713174550_b132-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"F1033","DOI":"10.1152\/ajprenal.00518.2009","article-title":"Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation","volume":"298","author":"Liu","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"key20200713174550_b133-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"F622","DOI":"10.1152\/ajprenal.00427.2004","article-title":"Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats","volume":"289","author":"Xia","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"key20200713174550_b134-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1172\/JCI0215493","article-title":"In vivo bradykinin B2 receptor activation reduces renal fibrosis","volume":"110","author":"Schanstra","year":"2002","journal-title":"J Clin Invest"},{"key":"key20200713174550_b135-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/toxsci\/kfn008","article-title":"Role of tissue kallikrein in prevention and recovery of gentamicin-induced renal injury","volume":"102","author":"Bledsoe","year":"2008","journal-title":"Toxicol Sci"},{"key":"key20200713174550_b136-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/S1567-5769(01)00109-6","article-title":"Kinin system in lupus nephritis","volume":"1","author":"Dellalibera-Joviliano","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"key20200713174550_b137-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1172\/JCI36728","article-title":"Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans","volume":"119","author":"Liu","year":"2009","journal-title":"J Clin Invest"},{"key":"key20200713174550_b138-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"e67790","DOI":"10.1371\/journal.pone.0067790","article-title":"Kallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stress","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"key20200713174550_b139-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1161\/01.HYP.0000110905.29389.e5","article-title":"Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis","volume":"43","author":"Xia","year":"2004","journal-title":"Hypertension"},{"key":"key20200713174550_b140-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1161\/01.STR.30.9.1925","article-title":"Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl salt-sensitive rats","volume":"30","author":"Zhang","year":"1999","journal-title":"Stroke"},{"key":"key20200713174550_b141-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1089\/hum.2006.17.206","article-title":"Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis","volume":"17","author":"Xia","year":"2006","journal-title":"Hum Gene Ther"},{"key":"key20200713174550_b142-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2741\/1886","article-title":"Experimental therapy with tissue kallikrein against cerebral ischemia","volume":"11","author":"Chao","year":"2006","journal-title":"Front Biosci"},{"key":"key20200713174550_b143-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1248\/yakushi.127.919","article-title":"Growth-stimulating effect of kallikrein on rat neural stem cells - II. Immunocytochemical analysis and specificity of the enzyme for neural stem cells","volume":"127","author":"Kizuki","year":"2007","journal-title":"Yakugaku Zasshi"},{"key":"key20200713174550_b144-ijmm-41-03-1177","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.bbrc.2011.02.112","article-title":"Tissue kallikrein protects cortical neurons against hypoxia\/reoxygenation injury via the ERK1\/2 pathway","volume":"407","author":"Liu","year":"2011","journal-title":"Biochem Biophys Res Commun"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T18:17:55Z","timestamp":1594664275000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2018.3361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,3]]},"references-count":144,"URL":"https:\/\/doi.org\/10.3892\/ijmm.2018.3361","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,3]]}}}